Adult
Age Factors
Aged
Anti-HIV Agents
/ therapeutic use
Asymptomatic Infections
/ epidemiology
Belgium
/ epidemiology
Bisexuality
Chancroid
/ epidemiology
Chlamydia Infections
/ epidemiology
Drug Resistance, Bacterial
/ genetics
Gonorrhea
/ epidemiology
HIV Infections
/ prevention & control
Homosexuality, Male
Humans
Incidence
Logistic Models
Lymphogranuloma Venereum
/ epidemiology
Macrolides
Male
Middle Aged
Mycoplasma Infections
/ epidemiology
Mycoplasma genitalium
/ genetics
Pre-Exposure Prophylaxis
Prevalence
RNA, Ribosomal, 23S
/ genetics
Sexual and Gender Minorities
/ statistics & numerical data
Syphilis
/ epidemiology
Young Adult
HIV pre-exposure prophylaxis
azithromycin
mycoplasma
Journal
Sexually transmitted infections
ISSN: 1472-3263
Titre abrégé: Sex Transm Infect
Pays: England
ID NLM: 9805554
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
24
10
2019
revised:
29
11
2019
accepted:
12
12
2019
pubmed:
4
1
2020
medline:
12
9
2020
entrez:
4
1
2020
Statut:
ppublish
Résumé
Recent evidence shows that patients using HIV pre-exposure prophylaxis (PrEP) have an increased rate of bacterial STIs, including syphilis, chlamydia and gonorrhoea. Our study aimed to describe the acquisition and the susceptibility for macrolides of We studied all MSM who started PrEP in the AZ Sint-Jan Hospital Bruges from 1 June 2017 to 31 March 2019 with at least one follow-up visit. Patients were screened for 131 MSM (median age 40 years, range 20-79) were included in the study. The median follow-up time was 12 months (IQR 6.1-17). Baseline prevalence of After initiation of PrEP, we found a stable incidence of almost exclusively asymptomatic
Identifiants
pubmed: 31896737
pii: sextrans-2019-054335
doi: 10.1136/sextrans-2019-054335
doi:
Substances chimiques
Anti-HIV Agents
0
Macrolides
0
RNA, Ribosomal, 23S
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
396-398Informations de copyright
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.